Top Pharmaceutical Employers
June 14, 2006careers
AstraZenecaAstraZeneca, the UK's second biggest home-grown big pharma company has continued to thrive over the last few years, despite some …
Cancer vaccine continues to show encouraging results
June 14, 2006Research and Development
Oxford BioMedica, the UK gene therapy specialist, has reported encouraging results from five phase II studies of TroVax, its leading …
Combination pill cuts heart attacks
June 13, 2006Sales and Marketing
New data on Pfizer's combination pill Caduet show it can cut the number of heart attacks and strokes in at-risk …
Blockbuster potential for diabetes vision drug
June 13, 2006Research and Development, Sales and Marketing
Lilly says new phase III data on its drug Arxxant shows it can stop diabetes patients losing their sight.Data from …
True scale of NHS deficits ‘masked’ says think tank
June 9, 2006Figures showing the NHS with debts of 512 million pounds are masking the true extent of the crisis, according to …
Relief for campaigners as NICE approves Herceptin
June 9, 2006Breast cancer drug campaigners have breathed a sigh of relief after NICE said Herceptin should be used to treat women …
Half of COPD patients misdiagnosed, says survey
June 9, 2006Sales and Marketing
A new survey of patients with chronic obstructive pulmonary disease has found nearly half have been misdiagnosed with asthma, meaning …
Humira gets go-ahead for the treatment of ankylosing spondylitis
June 9, 2006Sales and Marketing
Abbott has been given the green light to market Humira in Europe for the treatment of severe active ankylosing spondylitis.This …
China upholds Viagra patent
June 6, 2006Sales and Marketing
A Chinese court has come down on the side of Pfizer in the pharma company's battle to prevent local companies …
Avastin filed for advanced breast cancer
June 5, 2006Sales and Marketing
Roche and Genentech have filed Avastin in the US for first-line treatment of women with metastatic breast cancer.The drug has …
European agreement to improve children’s medicines
June 2, 2006Sales and Marketing
It will soon be easier for pharma companies to develop medicines specifically for children, after the European Parliament approved a …
OTC regulations to be streamlined
June 2, 2006Sales and Marketing
The rules governing the way over-the-counter medicines are regulated are set to change as the government strives to reduce the …
Practice ‘clusters’ urged to lead next phase of NHS revolution
June 2, 2006England's general practices are being urged to seize their opportunity to re-build the NHS as a primary care-led, patient-centred service, …
Outrage over NICE verdict on Alzheimer’s drugs
June 1, 2006Sales and Marketing
Hundreds of thousands of patients with early or late-onset Alzheimer's disease (AD) are to be denied access to four drugs …
Roundhouse joins Affiniti marketing communications group
May 30, 2006Medical Communications
Adventis, the multimedia marketing group has bought healthcare advertising agency Roundhouse for 1.6 million pounds as part of its expansion …
First private contractors to provide GP services
May 30, 2006Care UK has signed a contract to provide GP services in Barking and Dagenham, making it the first private company …
PCT mergers bring end to uncertainty
May 30, 2006The number of Primary Care Trusts in England is to be cut in half from 303 to just 152, the …
GSK investors opt for anonymity in face of animal extremist threat
May 30, 2006Sales and Marketing
GlaxoSmithKline shareholders are using an administrative loophole to protect themselves in the face of a threatening letter campaign by animal …
Acomplia poised for approval as NHS focuses on fighting fat
May 30, 2006Sales and Marketing
Acomplia, the first-of-a-kind weight-loss drug, is set to gain approval across Europe within the coming weeks, offering a new hope …
NICE set to recommend new ‘gold standard’ treatments for early-stage breast cancer
May 30, 2006Three early breast cancer drugs are a step closer to overtaking the current gold standard treatment, after preliminary recommendation from …
Latest content
